Back
Cartesian Therapeutics Stock Predictions
![](/images/offers/ims/large/offer19.jpg)
Free presentation on how to trade options for overnight gains
Get the free overnight options training here.
Sell
25
RNAC
Cartesian Therapeutics
Last Price:
12.91
Seasonality Move:
-10.23%
7 Day Trial
ALL ACCESS PASS
$
7
![](/images/offers/ims/large/offer8.jpg)
Forget AI THIS is Way Bigger
If you've never heard of "QaaS" technology you need to click here now.Cartesian Therapeutics Stock Forecast
- Over the next 52 weeks, Cartesian Therapeutics has on average historically fallen by 10.7% based on the past 8 years of stock performance.
- Cartesian Therapeutics has fallen lower in 5 of those 8 years over the subsequent 52-week period, corresponding to a historical accuracy of 62.5%
-
Is Cartesian Therapeutics Stock Undervalued?
The current Cartesian Therapeutics [RNAC] share price is $12.98. The Score for RNAC is 25, which is 50% below its historic median score of 50, and infers higher risk than normal. - RNAC is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
Will Cartesian Therapeutics Stock Go Up Next Year?
- Over the next 52 weeks, Cartesian Therapeutics has on average historically fallen by 10.7% based on the past 8 years of stock performance.
Cartesian Therapeutics Stock Rating
Sell
25
Cartesian Therapeutics (RNAC)
is a Sell
Is Cartesian Therapeutics overpriced?
- Cartesian Therapeutics has fallen lower in 5 of those 8 years over the subsequent 52-week period, corresponding to a historical accuracy of 62.5%
Cartesian Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
cartesiantherapeutics.com
52-Week Data
52-Week High:
42.60
52-Week Low:
11.67
Prediction Charts
Market Cap:
277.54M
Price in USD:
12.98
Volume:
53.5K
Beta:
0.77
Technical Analysis
SMA50:
16.01
SMA100:
20.73
SMA200:
21.37
52-Wk Change:
-62.38%
Stock Predictions
-
Is Cartesian Therapeutics stock public?
Yes, Cartesian Therapeutics is a publicly traded company. -
What is the Cartesian Therapeutics stock quote today?
The Cartesian Therapeutics stock price is 12.98 USD today. -
How to buy Cartesian Therapeutics stock online?
You can buy Cartesian Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Aug-19 | 14.10 | 14.66 | 15.60 | 13.77 |
Aug-20 | 15.27 | 14.39 | 15.35 | 14.15 |
Aug-21 | 14.60 | 14.88 | 15.10 | 14.21 |
Aug-22 | 15.08 | 13.64 | 15.29 | 13.33 |
Aug-23 | 13.42 | 13.75 | 14.11 | 13.19 |
Aug-26 | 14.00 | 13.96 | 14.15 | 13.40 |
Aug-27 | 13.98 | 14.04 | 14.25 | 13.63 |
Aug-28 | 14.11 | 14.24 | 14.51 | 13.81 |
Aug-29 | 14.37 | 14.91 | 15.33 | 14.27 |
Aug-30 | 14.85 | 14.06 | 14.85 | 13.78 |
Sep-3 | 13.72 | 13.13 | 13.83 | 13.01 |
Sep-4 | 13.05 | 13.46 | 13.95 | 13.05 |
Sep-5 | 13.49 | 13.98 | 14.24 | 13.15 |
Sep-6 | 14.04 | 12.98 | 14.28 | 12.80 |
Cartesian Therapeutics Earnings
Cartesian Therapeutics Earnings Report: Per Share Cartesian Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
Cartesian Therapeutics Forecast Revenue Growth
Cartesian Therapeutics Stock Analysis: Historical quarterly revenues per share for Cartesian Therapeutics and historical quarterly revenue growth:
- Analysts estimate an earnings increase this quarter of $1.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $5.90 per share, and an increase next year of $2.16 per share.
* Cartesian Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.